case_images: PMC10214075_01
case_images: Physical activity (PA) and moderate to vigorous physical activity (mvPA).
  : diagnosis;
  : chemotherapy
  FOLFIRINOX course; :
  surgery.
case_images: 10.1177_20552076231177127-fig1.jpg
case_images: PMC10214075_01_10.1177_20552076231177127-fig1.jpg
case_images: fig1-20552076231177127
case_images: PA and mvPA declined after the onset of symptoms in November '20, increased in March '21 (without chemotherapy and before surgery), then declined after surgery and then gradually increased; mvPA increased above baseline values after the end of treatment (Figure 1).
case_images: Estimated maximal oxygen uptake (est. VO2max). : diagnosis; : chemotherapy FOLFIRINOX course;
  : surgery.
case_images: 10.1177_20552076231177127-fig2.jpg
case_images: PMC10214075_01_10.1177_20552076231177127-fig2.jpg
case_images: fig2-20552076231177127
case_images: Est.VO2max remained stable from baseline until surgery the end of March '21, then decreased, recovered somewhat in May '21-June '21 and remained stable from July '21 until March '22 and recovered until baseline from April '22 to July '22 (Figure 2).
case_images: Heart rate variability (HRV) and heart rate frequency at rest (hRrest). : diagnosis; : chemotherapy FOLFIRINOX course;
  : surgery.
case_images: 10.1177_20552076231177127-fig3.jpg
case_images: PMC10214075_01_10.1177_20552076231177127-fig3.jpg
case_images: fig3-20552076231177127